Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer
Clinical trial NCT04498689 · UNKNOWN
Trial details
- NCT number
- NCT04498689
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-01
- Primary completion
- 2022-12-31
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.